285 related articles for article (PubMed ID: 18222230)
1. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors.
Wright CD; Choi NC; Wain JC; Mathisen DJ; Lynch TJ; Fidias P
Ann Thorac Surg; 2008 Feb; 85(2):385-9. PubMed ID: 18222230
[TBL] [Abstract][Full Text] [Related]
2. Role of chemotherapy in the management of advanced thymic tumors.
Evans TL; Lynch TJ
Semin Thorac Cardiovasc Surg; 2005; 17(1):41-50. PubMed ID: 16104360
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.
Korst RJ; Bezjak A; Blackmon S; Choi N; Fidias P; Liu G; Marx A; Wright C; Mock S; Rutledge JR; Keshavjee S
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):36-44, 46.e1. PubMed ID: 24139613
[TBL] [Abstract][Full Text] [Related]
4. Successful long-term outcome in locally advanced Masaoka IVA thymoma with induction chemotherapy followed by complete resection and adjuvant radiotherapy.
Cohn HE
Ann Thorac Surg; 2008 Nov; 86(5):1725; author reply 1725. PubMed ID: 19049801
[No Abstract] [Full Text] [Related]
5. Thymic carcinoma: outcomes after surgical resection.
Okereke IC; Kesler KA; Freeman RK; Rieger KM; Birdas TJ; Ascioti AJ; Badve S; Nelson RP; Loehrer PJ
Ann Thorac Surg; 2012 May; 93(5):1668-72; discussion 1672-3. PubMed ID: 22421590
[TBL] [Abstract][Full Text] [Related]
6. Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules.
Yano M; Sasaki H; Yukiue H; Kawano O; Okuda K; Hikosaka Y; Fujii Y
World J Surg; 2009 Jul; 33(7):1425-31. PubMed ID: 19424745
[TBL] [Abstract][Full Text] [Related]
7. Multimodality treatments in locally advanced stage thymomas.
Hassan M; Seoud DE
Hematol Oncol Stem Cell Ther; 2009; 2(2):340-4. PubMed ID: 20118057
[TBL] [Abstract][Full Text] [Related]
8. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan.
Okuda K; Yano M; Yoshino I; Okumura M; Higashiyama M; Suzuki K; Tsuchida M; Usuda J; Tateyama H
Ann Thorac Surg; 2014 May; 97(5):1743-8. PubMed ID: 24657034
[TBL] [Abstract][Full Text] [Related]
9. Multimodality therapy for locally advanced thymomas: state of the art or investigational therapy?
Huang J; Riely GJ; Rosenzweig KE; Rusch VW
Ann Thorac Surg; 2008 Feb; 85(2):365-7. PubMed ID: 18222226
[No Abstract] [Full Text] [Related]
10. Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database.
Leuzzi G; Rocco G; Ruffini E; Sperduti I; Detterbeck F; Weder W; Venuta F; Van Raemdonck D; Thomas P; Facciolo F;
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):47-57.e1. PubMed ID: 26403869
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers.
Marulli G; Lucchi M; Margaritora S; Cardillo G; Mussi A; Cusumano G; Carleo F; Rea F
Eur J Cardiothorac Surg; 2011 Mar; 39(3):e1-7. PubMed ID: 21193321
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy.
Ishikawa Y; Matsuguma H; Nakahara R; Suzuki H; Ui A; Kondo T; Kamiyama Y; Igarashi S; Mori K; Kodama T; Yokoi K
Ann Thorac Surg; 2009 Sep; 88(3):952-7. PubMed ID: 19699926
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV; Khuri FR; Hong WK; Shin DM
Lung Cancer; 2004 Jun; 44(3):369-79. PubMed ID: 15140551
[TBL] [Abstract][Full Text] [Related]
14. Outcome of multimodality treatment for 188 cases of type B3 thymoma.
Gao L; Wang C; Fang W; Zhang J; Lv C; Fu S
J Thorac Oncol; 2013 Oct; 8(10):1329-34. PubMed ID: 24457243
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after multimodality treatment for stage III thymic tumors.
Venuta F; Rendina EA; Longo F; De Giacomo T; Anile M; Mercadante E; Ventura L; Osti MF; Francioni F; Coloni GF
Ann Thorac Surg; 2003 Dec; 76(6):1866-72; discussion 1872. PubMed ID: 14667602
[TBL] [Abstract][Full Text] [Related]
16. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma.
Kawasaki H; Taira N; Ichi T; Yohena T; Kawabata T; Ishikawa K
Eur J Surg Oncol; 2014 Sep; 40(9):1151-5. PubMed ID: 24703656
[TBL] [Abstract][Full Text] [Related]
17. Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome.
Ried M; Potzger T; Sziklavari Z; Diez C; Neu R; Schalke B; Hofmann HS
Thorac Cardiovasc Surg; 2014 Mar; 62(2):161-8. PubMed ID: 23775415
[TBL] [Abstract][Full Text] [Related]
18. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
[TBL] [Abstract][Full Text] [Related]
19. Trimodality Therapy for an Advanced Thymic Carcinoma With Both Aorta and Vena Cava Invasion.
Momozane T; Inoue M; Shintani Y; Funaki S; Kawamura T; Minami M; Shirakawa Y; Kuratani T; Sawa Y; Okumura M
Ann Thorac Surg; 2016 Aug; 102(2):e139-41. PubMed ID: 27449450
[TBL] [Abstract][Full Text] [Related]
20. A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumors.
Park S; Ahn MJ; Ahn JS; Sun JM; Shim YM; Kim J; Choi YS; Kim K; Shin S; Ahn Y; Kwon OJ; Kim H; Lee SJ; Chang WJ; Park K
J Thorac Oncol; 2013 Jul; 8(7):959-66. PubMed ID: 23722169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
